Skip to main content

Hoelscher Paul W.'s Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Apr 22, 2022

Accession no.
0001209191-22-025455
Filed
Apr 22, 2022
Trade date
Apr 20, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.74M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoelscher Paul W.CIK 0001611468Officer (EVP, CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 20, 2022Ordinary SharesMOption exerciseAcquired+50,000$22.14+$1,107,00051,049Direct
Apr 20, 2022Ordinary SharesSSaleDisposed−28,458$114.36−$3,254,456.8822,591Direct
Apr 20, 2022Ordinary SharesSSaleDisposed−21,542$115.17−$2,480,992.141,049Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 20, 2022Ordinary SharesMOption exerciseDisposed−50,000$0.00$036,424Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)